Multiplex Assay Kit for Histidine Rich Glycoprotein (HRG) ,etc. by FLIA (Flow Luminescence Immunoassay)

HPRG; HRGP; Histidine-Proline Rich Glycoprotein; Thrombophilia Due To Elevated HRG

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Histidine Rich Glycoprotein (HRG) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Histidine Rich Glycoprotein (HRG) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Histidine Rich Glycoprotein (HRG) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Histidine Rich Glycoprotein (HRG) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 78-95 82
EDTA plasma(n=5) 85-96 89
heparin plasma(n=5) 79-92 85

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Histidine Rich Glycoprotein (HRG) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Histidine Rich Glycoprotein (HRG) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Histidine Rich Glycoprotein (HRG) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 88-95% 98-105% 85-95% 85-101%
EDTA plasma(n=5) 80-105% 95-104% 80-90% 96-105%
heparin plasma(n=5) 80-98% 84-98% 99-105% 90-98%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:HRG) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
J. Proteome Res. Identification and Confirmation of Differentially Expressed Fucosylated Glycoproteins in the Serum of Ovarian Cancer Patients Using a Lectin Array and LC–MS/MS ACS: pr300330z
Medical Oncology Evaluation of histidine-rich glycoprotein tissue RNA and serum protein as novel markers for breast cancer Springer: Source
Int J Cancer The nuclear bile acid receptor FXR controls the liver derived tumor suppressor histidine‐rich glycoprotein PubMed: 25363753
Nucleic Acid Therapeutics Pharmacokinetic and Pharmacodynamic Investigations of ION-353382, a Model Antisense Oligonucleotide: Using Alpha-2-Macroglobulin and Murinoglobulin Double-Knockout Mice Pubmed:27031383
United States Patent Application Compositions and Methods for Diagnosing Lung Cancer y2016:0077095.html
Hypertension Research Combination of serum histidine-rich glycoprotein and uterine artery Doppler to predict preeclampsia Pubmed:29416108
journal of histochemistry & cytochemistry Ultrastructural Localization of Histidine-rich Glycoprotein in Skeletal Muscle Fibers: Colocalization With AMP Deaminase Pubmed: 31880188
DOKLADY BIOCHEMISTRY AND BIOPHYSICS Personalized Approach to Determination of Histidine-Rich Glycoprotein and E-Cadherin in Supernatants of Immunocompetent Blood Cells and Breast Biopsy … Pubmed: 32342301
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPC534Hu01 Recombinant Histidine Rich Glycoprotein (HRG) Positive Control; Immunogen; SDS-PAGE; WB.
APC534Hu61 Active Histidine Rich Glycoprotein (HRG) Cell culture; Activity Assays.
EPC534Hu61 Eukaryotic Histidine Rich Glycoprotein (HRG) Positive Control; Immunogen; SDS-PAGE; WB.
PAC534Hu01 Polyclonal Antibody to Histidine Rich Glycoprotein (HRG) WB; IHC; ICC; IP.
LAC534Hu71 Biotin-Linked Polyclonal Antibody to Histidine Rich Glycoprotein (HRG) WB; IHC; ICC.
MAC534Hu24 Monoclonal Antibody to Histidine Rich Glycoprotein (HRG) WB; IHC; ICC; IP.
MAC534Hu22 Monoclonal Antibody to Histidine Rich Glycoprotein (HRG) WB; IHC; ICC; IP.
MAC534Hu21 Monoclonal Antibody to Histidine Rich Glycoprotein (HRG) WB; IHC; ICC; IP.
MAC534Hu23 Monoclonal Antibody to Histidine Rich Glycoprotein (HRG) WB; IHC; ICC; IP.
MAC534Hu26 Monoclonal Antibody to Histidine Rich Glycoprotein (HRG) WB; IHC; ICC; IP.
SEC534Hu ELISA Kit for Histidine Rich Glycoprotein (HRG) Enzyme-linked immunosorbent assay for Antigen Detection.
LMC534Hu Multiplex Assay Kit for Histidine Rich Glycoprotein (HRG) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.